Spots Global Cancer Trial Database for Expanded Access for Marizomib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access for Marizomib
Official Title: Expanded Access for Marizomib
Study ID: NCT04644107
Conditions
Solid Tumor
Interventions
Marizomib
Study Description
Brief Summary: This is an expanded access program (EAP) for eligible participants designed to provide access to Marizomib.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Bristol Myers Squibb, Summit, New Jersey, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
